Company Overview

Development Stage

About the Company

[Summary] To provide patients with trustworthy and affordable innovative biologi

Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. (hereinafter referred to as "Zhixiang Jintai" or "the Company") was founded in 2015 and is a biopharmaceutical enterprise listed on the STAR Market (stock code: 688443) that integrates R&D, production, and commercialization. The Company focuses on three major areas: autoimmune diseases, infectious diseases, and oncology. It pays attention to unmet clinical needs and the accessibility of innovative drugs, and continuously develops monoclonal antibody and bispecific antibody drugs.
Zhixiang Jintai has established a full-industry-chain technology platform, covering innovative target discovery research, screening of antibody molecules with independent intellectual property rights and druggability research, preclinical evaluation and clinical trials, pilot process scale-up, commercial production, and marketing. Driven by innovation, the Company has established three major antibody drug R&D centers in Beijing, Shanghai, and Chongqing, creating a full-process antibody drug development system.
Zhixiang Jintai always puts patients at the center, continuously fulfills its corporate mission of "providing patients with trustworthy and affordable innovative biologics," continuously develops its product pipeline, expands new indications, strives to improve and enhance people's health, and gives back to employees, shareholders, and society.

For more information, please visit the official website of Zhixiang Jintai: *

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Zhixiang Jintai Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal: 上交所

Zhixiang Jintai How Fast Is Hiring Growing? (119 open positions)

Manage
Note: How fast is hiring at Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. growing? Zhixiang Jintai2025: 318 openings (up 200%), 2024: 106 openings (up 179%), 2023: 38 openings, 2021: 50 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Zhixiang Jintai Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 63%
  • 2024: Up 700%
Zhixiang Jintai Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. growing? Zhixiang JintaiMaster's recruitment over the years: 2025: 13 openings (up 63%), 2024: 8 openings (up 700%), 2023: 1 openings.

Zhixiang Jintai R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd.? Based on an analysis of Zhixiang Jintai's job postings over the past year, "医疗卫生/美容保健类" demand: 17.9%, "计算机/网络/技术类": 16.7%, "生物/制药/化工/环保类": 10.9%, "其他(研发和技术类)": 1.6%, "机械/仪器仪表类": 1.4%, "电气/能源/动力类": 1.4%. For reference only.

Zhixiang Jintai — What Are the Salaries Like? (449 records)

Manage
salary range: 3K - 50K, 47% of roles pay ¥10-20K
Note: salary statistics are based on 449 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd.?Zhixiang Jintai47% of positions earn 10-20K, Fresh graduate salary: ¥3.6K。Chongqing salary ranking: #421,销售类 average salary ¥16.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Zhixiang Jintai

(More)
Are salaries high at Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd.? We provide: 医药代表,信息,实习生,qa,地区经理,零售,hr,市场,运营,合规,质量,销售,细胞培养,财务,bp,医学经理,安全,验证主管,qc,仓库. Click to view detailed salary analysis by job.

Zhixiang Jintai — Fortune 500? (More)

Yes, ranked in 中国新经济500强:

Zhixiang Jintai honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Zhixiang Jintai Related Industry Tags

Job Category

  • 销售类
    47.5% of total 47.5%
  • 医疗卫生/美容保健类
    17.7% of total 17.7%
  • 计算机/网络/技术类
    16.4% of total 16.4%
  • 经营管理类
    16% of total 16%

Education

  • 本科
    74.7% of total 74.7%
  • 大专
    16.2% of total 16.2%
  • 不限
    5.1% of total 5.1%
  • 硕士
    3.8% of total 3.8%

Experience

  • 1-3年
    44.1% of total 44.1%
  • 3-5年
    23.5% of total 23.5%
  • 不限
    16.4% of total 16.4%
  • 5-10年
    12.2% of total 12.2%
View Detailed Analysis

What does Chongqing Zhixiang Jintai Biopharmaceutical Co., Ltd. require? Who is Zhixiang Jintai hiring? Zhixiang Jintai recruitment: 销售类占比最多占47.5%,其次是医疗卫生/美容保健类占17.7%. What education can get in at Zhixiang Jintai? 本科占比最多占74.7%,其次是大专占16.2%. High education required at Zhixiang Jintai? 硕士占3.8%,博士占0.2%. Work experience required at Zhixiang Jintai? 1-3年占比最多占44.1%,其次是3-5年占23.5%. Where are the job locations at Zhixiang Jintai? 重庆占比最多占46.8%,其次是上海占11.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 36,668万(元)
Legal Representative: 刘志刚
Date Established:
Credit Code: 91500113MA5U36LJ53
Registered Address: 重庆市巴南区麻柳大道699号2号楼A区

Partners & Suppliers

与智翔金泰签署战略合作,就赛立奇单抗在上海及华东区域的商业化深度合作 Source
合作客户 医药流通
与智翔金泰达成战略合作,作为赛立奇单抗的区域经销商,覆盖医疗终端及零售渠道 Source
合作客户 医药流通
作为赛立奇单抗(金立希)的全国战略经销商,负责药品分销、物流及市场推广 Source
合作客户 医药流通
签署战略合作协议,提供细胞培养基及抗体药物CDMO服务 Source
供应商 CDMO
提供一次性生物反应器、切向流过滤系统及完整性测试仪等核心生产设备 Source
供应商 生物工艺设备

People who follow Zhixiang Jintai also follow

Zhixiang Jintai Competitors (Similar Companies)

“Pharmaceutical Custom R&D and Manufacturing”
“Serving human pharmaceutical and health undertakings”
“连续多年位居国内皮肤临床用药领导地位”
“Virtue over the world, medicine benefits all”
“The company is a group pharmaceutical enterprise integrating R&D, prod”
“Custom chemical synthesis, pharmaceutical intermediates, and new drug ”
制药/药业 医药 药物研发 生物制品
“Primarily engaged in the research and development, production, and sal”
“Be a good person, produce good medicine.”
“Leading enterprise of the National Biological Industry Base”
“Key pharmaceutical enterprise in Chongqing”
医药营销 药物研发 生物医药 大健康
体外诊断试剂 诊断试剂 试剂 抗体
建筑工程 施工总承包 公路工程 市政公用工程
生物制品 抗生素 中成药 原料药

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates